Related Experiment Video
Updated: Feb 11, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Downregulation of BRAF-activated non-protein coding RNA in patients with hepatitis B virus-associated hepatocellular
Na-Na Zhao1, Cheng Wang2, Cheng-Cai Lai3
1Department of Hepatobiliary Surgery, Beijing 302 Hospital, Beijing 100039, P.R. China.
Abstract:
Long non-coding RNAs (lncRNAs) have been investigated as a novel class of regulators of cellular processes, including cell growth, apoptosis and carcinogenesis. lncRNA BRAF-activated non-protein coding RNA (BANCR) has recently been revealed to be involved in tumorigenesis of numerous types of cancer, including papillary thyroid carcinoma, melanoma, non-small cell lung cancer and colorectal cancer. However, the expression profiles and biological relevance of lncRNA BANCR in hepatocellular carcinoma (HCC) has not yet been reported. In the present study, the expression level of BANCR in tumor tissues and para-cancerous tissues was determined by reverse transcription-quantitative polymerase chain reaction in patients with hepatitis B virus (HBV)-associated HCC, and its association with clinicopathological characteristics of patients was analyzed. The results demonstrated that the expression level of BANCR was significantly reduced in tumor tissues in comparison with in para-cancerous tissues (P<0.001). Furthermore, the present study demonstrated that BANCR expression level was closely associated with serum α-fetoprotein levels (P<0.01) and HCC tumor number (P<0.05). To the best of our knowledge, these results revealed for the first time that BANCR downregulated in patients with HBV-associated HCC and BANCR expression level may be a potential valuable diagnosis and therapeutic biomarker in HCC.
Insights
Long non-coding RNA BANCR (BRAF-activated non-protein coding RNA) is downregulated in hepatitis B virus-associated hepatocellular carcinoma. This finding suggests BANCR may serve as a diagnostic and therapeutic biomarker for liver cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are emerging regulators of cellular functions, including cancer development.
- The lncRNA BRAF-activated non-protein coding RNA (BANCR) is implicated in various cancers but its role in hepatocellular carcinoma (HCC) remains uninvestigated.
Purpose of the Study:
- To investigate the expression profile of lncRNA BANCR in hepatitis B virus-associated HCC.
- To analyze the correlation between BANCR expression and clinicopathological features in HCC patients.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to measure BANCR expression levels in tumor and adjacent non-tumor tissues.
- Statistical analysis was performed to associate BANCR expression with clinicopathological characteristics.
Main Results:
- BANCR expression was significantly downregulated in HCC tumor tissues compared to para-cancerous tissues (P<0.001).
- Reduced BANCR expression correlated with elevated serum α-fetoprotein levels (P<0.01) and increased tumor number (P<0.05).
Conclusions:
- This study is the first to report the downregulation of BANCR in HBV-associated HCC.
- lncRNA BANCR may serve as a potential diagnostic and therapeutic biomarker for HCC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
What are Viruses?
RNA Polymerase II Accessory Proteins
Viruses with RNA Genomes
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
RNA Splicing

